CELLEBRITE DI LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.88 USD | +1.59% |
|
+3.92% | +25.64% |
| 19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
| 01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
| Sales 2024 * | 376M 31.36B | Sales 2025 * | 445M 37.13B | Capitalization | 2.23B 186B |
|---|---|---|---|---|---|
| Net income 2024 * | 38M 3.17B | Net income 2025 * | 51M 4.25B | EV / Sales 2024 * | 5.15 x |
| Net cash position 2024 * | 298M 24.86B | Net cash position 2025 * | 426M 35.55B | EV / Sales 2025 * | 4.06 x |
| P/E ratio 2024 * |
68.3
x | P/E ratio 2025 * |
45.8
x | Employees | 1,008 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.13% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cellebrite DI Ltd.
More recommendations
More press releases
More news
| 1 day | +1.59% | ||
| 1 week | +3.92% | ||
| Current month | -1.81% | ||
| 1 month | -4.98% | ||
| 3 months | +17.62% | ||
| 6 months | +68.68% | ||
| Current year | +25.64% |
1 week
10.28
10.89
1 month
10.2811.47
Current year
7.9112.50
1 year
5.2212.50
3 years
3.8013.24
5 years
0.0013.24
10 years
0.0013.24
| Managers | Title | Age | Since |
|---|---|---|---|
Yossi Carmil
CEO | Chief Executive Officer | 57 | 01/04/01 |
Dana Gerner
DFI | Director of Finance/CFO | 56 | 07/14/07 |
Ayala Shapira
CMP | Compliance Officer | 53 | 03/22/03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Adam Clammer
BRD | Director/Board Member | 53 | 30/21/30 |
Thomas Hogan
CHM | Chairman | 64 | 08/23/08 |
Dafna Gruber
BRD | Director/Board Member | 58 | 30/21/30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 10.88 | +1.59% | 429,966 |
| 25/24/25 | 10.71 | 0.00% | 456,417 |
| 24/24/24 | 10.71 | 0.00% | 460,786 |
| 23/24/23 | 10.71 | +2.29% | 490,387 |
| 22/24/22 | 10.47 | 0.00% | 385,937 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotes
Cellebrite DI Ltd is an Israel-based software developer. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Platform enables users to collect, view, analyse and manage digital data throughout the entire investigation cycle. The Company's platform improves the investigation process for public defenders, police departments, state departments, armed services, legal and corporate security; this leads to an accelerated speed of investigations and increased crime clearance rates.
Sector
Software
Calendar
23/05/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
10.88
USD
Average target price
13.64
USD
Spread / Average Target
+25.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.64% | 2.23B | |
| +8.05% | 3,020B | |
| +5.58% | 82.93B | |
| +3.69% | 76.85B | |
| -14.62% | 53.04B | |
| +31.16% | 50.15B | |
| -24.56% | 46.71B | |
| +17.75% | 41.41B | |
| +55.21% | 36.1B | |
| -10.24% | 24.64B |
- Stock Market
- Equities
- CLBT Stock
